User talk:GJeffery

Welcome!

Hello, and welcome to Wikipedia. Thank you for your contributions. I hope you like the place and decide to stay. Here are a few good links for newcomers:

I hope you enjoy editing here and being a Wikipedian! By the way, you can sign your name on Talk and vote pages using three tildes, like this: ~~~. Four tildes (~~~~) produces your name and the current date. If you have any questions, see the help pages, add a question to the village pump or ask me on my Talk page. Again, welcome! -- Graham ☺ | Talk 17:18, 18 Nov 2004 (UTC)

Hey GJeffery, it's quite obvious whom you work for, uh? Welcome, and I hope you can add to articles like pharmaceutical company, drug design, surrogate endpoint and the like... JFW | T@lk 21:00, 18 Nov 2004 (UTC)

Lindberg[edit]

Hello. In central limit theorem the link to Lindeberg goes to a blank page, and if there is an article about him, I'd expect to find it under a more appropriate title that includes his first name. To link only to surnames is to run the risk of linking to Abel when one intends the mathematician Niels Henrik Abel, whereas the page titled Abel is (of course!) about the brother of Cain in the book of Genesis. (Someone actually created several such links to Abel in some articles on math; illustrating once again that common sense does not always prevail). Michael Hardy 00:02, 28 Nov 2004 (UTC)

Article Licensing[edit]

Hi, I've started a drive to get users to multi-license all of their contributions that they've made to either (1) all U.S. state, county, and city articles or (2) all articles, using the Creative Commons Attribution-Share Alike (CC-by-sa) v1.0 and v2.0 Licenses or into the public domain if they prefer. The CC-by-sa license is a true free documentation license that is similar to Wikipedia's license, the GFDL, but it allows other projects, such as WikiTravel, to use our articles. Since you are among the top 2000 Wikipedians by edits, I was wondering if you would be willing to multi-license all of your contributions or at minimum those on the geographic articles. Over 90% of people asked have agreed. For More Information:

Multi-Licensing FAQ - Lots of questions answered
Multi-Licensing Guide
Free the Rambot Articles Project

To allow us to track those users who muli-license their contributions, many users copy and paste the "{{DualLicenseWithCC-BySA-Dual}}" template into their user page, but there are other options at Template messages/User namespace. The following examples could also copied and pasted into your user page:

Option 1

I agree to [[Wikipedia:Multi-licensing|multi-license]] all my contributions, with the exception of my user pages, as described below:

OR

Option 2

I agree to [[Wikipedia:Multi-licensing|multi-license]] all my contributions to any [[U.S. state]], county, or city article as described below:

Or if you wanted to place your work into the public domain, you could replace "{{DualLicenseWithCC-BySA-Dual}}" with "{{MultiLicensePD}}". If you only prefer using the GFDL, I would like to know that too. Please let me know what you think at my talk page. It's important to know either way so no one keeps asking. -- Ram-Man (comment| talk)

Medicines[edit]

Hi GJeffery, my compliments on your valuable additions to medication articles. I'm in little doubt about who employs you :-) - could you give me the inside dirt about the FDA approval for ximelagatran?

Please consider joining Wikiproject "Drugs", which is a loose gathering of pharmaceutics enthusiasts.

Please have a look at Category:Pharmacologic agents. Ideally, all articles about medication should be in subcategories of this overarching "pills & drugs" category.

Also, would you have access to public domain images of drug molecules? Generally, User:Mykhal has been drawing drugs for me, because mine were always full of mistakes :-). This looks nice whenever the Template:Drugbox is added. The Drugbox is a pan-Wikipedia drug information tool. JFW | T@lk 19:21, 12 Dec 2004 (UTC)

Okay, so when you're done with AstraZeneca, you'll carry on with Bristol-Myers-Squibb :-)

Will you join the WikiProject? And would you have any quick way of getting drug molecule images? JFW | T@lk 19:42, 12 Dec 2004 (UTC)

Hello, you left a message for me yesterday. I'm sorry, I wasn't trying to mess with your home page, just remove a link to an article that was no longer there. I'm not trying to spoil your work--my intention was only to merge articles that I thought had been voted on as needing merging into one larger article. 68.88.233.11 08:15, 30 Dec 2004 (UTC)

Amanullah Khan[edit]

Thanks for adding the photo of Amanullah Khan! It helps bring the article to life. – Quadell ^{(talk) (help)} 22:53, Jan 23, 2005 (UTC)

Machine Gun Corps[edit]

By all means let's use English. A competent user of that language would not use 'potential' when he meant 'potentiality' any more readily than he would write 'flying' when he meant 'swimming'. It is saddening to see a language which was subtle, expressive and full of potentiality reduced to relative impotence by people who seem determined to remain ignorant of its potential qualities.

List of best-selling drugs[edit]

I've seen you created an article with the list of the 200 best-selling drugs, which appears to be a copy of an (subscription-requiring) article from MedAdNews.

Are you sure you're not commiting any copyright violation of MedAdNews by posting that information to a wikipedia article??

Regards, -- Iván Sánchez ^(talk) 17:47, 27 August 2007 (UTC)[reply]

Image source problem with Image:Bayerlogo.gif[edit]

Image Copyright problem

This is an automated message from a robot. You have recently uploaded Image:Bayerlogo.gif. The file's description page currently doesn't specify who created the content, so the copyright status is unclear. If you did not create this file yourself, you will need to specify the owner of the copyright. If you obtained it from a website, then a link to the website from which it was taken, together with a restatement of that website's terms of use of its content, is usually sufficient information. However, if the copyright holder is different from the website's publisher, their copyright should also be acknowledged.

As well as adding the source, please add a proper copyright licensing tag if the file doesn't have one already. If you created/took the picture, audio, or video then the {{GFDL-self}} tag can be used to release it under the GFDL. If you believe the media meets the criteria at Wikipedia:Non-free content, use a tag such as {{non-free fair use in|article name}} or one of the other tags listed at Wikipedia:Image copyright tags#Fair use. See Wikipedia:Image copyright tags for the full list of copyright tags that you can use.

If you have uploaded other files, consider checking that you have specified their source and tagged them, too. You can find a list of files you have uploaded by following this link. Unsourced and untagged images may be deleted one week after they have been tagged, as described on criteria for speedy deletion. If the image is copyrighted under a non-free license (per Wikipedia:Fair use) then the image will be deleted 48 hours after 14:21, 12 September 2007 (UTC). If you have any questions please ask them at the Media copyright questions page. If you believe you received this message in error, please notify the bot's owner. OsamaKBOT 14:21, 12 September 2007 (UTC)[reply]

2007 List of Top Pharma[edit]

Do you have the 2007 list of the top 50 pharmaceutical companies? --Cff12345 (talk) 02:48, 10 February 2008 (UTC)[reply]

Has the 2007 Top Pharma list been published yet? --Cff12345 (talk) 22:30, 8 November 2008 (UTC)[reply]

Attention-focusing method[edit]

A proposed deletion template has been added to the article Attention-focusing method, suggesting that it be deleted according to the proposed deletion process. All contributions are appreciated, but this article may not satisfy Wikipedia's criteria for inclusion, and the deletion notice should explain why (see also "What Wikipedia is not" and Wikipedia's deletion policy). You may prevent the proposed deletion by removing the {{dated prod}} notice, but please explain why you disagree with the proposed deletion in your edit summary or on its talk page.

Please consider improving the article to address the issues raised because even though removing the deletion notice will prevent deletion through the proposed deletion process, the article may still be deleted if it matches any of the speedy deletion criteria or it can be sent to Articles for Deletion, where it may be deleted if consensus to delete is reached. Do you want to opt out of receiving this notice? DGG (talk) 20:35, 2 May 2008 (UTC)[reply]

Astellas Pharma[edit]

Hello, this is a message from an automated bot. A tag has been placed on Astellas Pharma, by another Wikipedia user, requesting that it be speedily deleted from Wikipedia. The tag claims that it should be speedily deleted because Astellas Pharma is pure vandalism; this includes redirects created during cleanup of page move vandalism.

To contest the tagging and request that administrators wait before possibly deleting Astellas Pharma, please affix the template {{hangon}} to the page, and put a note on its talk page. If the article has already been deleted, see the advice and instructions at WP:WMD. Feel free to contact the bot operator if you have any questions about this or any problems with this bot, bearing in mind that this bot is only informing you of the nomination for speedy deletion; it does not perform any nominations or deletions itself. CSDWarnBot (talk) 23:10, 13 February 2009 (UTC)[reply]

ArbCom elections are now open![edit]

Hi,
You appear to be eligible to vote in the current Arbitration Committee election. The Arbitration Committee is the panel of editors responsible for conducting the Wikipedia arbitration process. It has the authority to enact binding solutions for disputes between editors, primarily related to serious behavioural issues that the community has been unable to resolve. This includes the ability to impose site bans, topic bans, editing restrictions, and other measures needed to maintain our editing environment. The arbitration policy describes the Committee's roles and responsibilities in greater detail. If you wish to participate, you are welcome to review the candidates' statements and submit your choices on the voting page. For the Election committee, MediaWiki message delivery (talk) 12:53, 23 November 2015 (UTC)[reply]

Nomination of TAP Pharmaceutical Products for deletion[edit]

A discussion is taking place as to whether the article TAP Pharmaceutical Products is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Wikipedia:Articles for deletion/TAP Pharmaceutical Products until a consensus is reached, and anyone is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Rathfelder (talk) 20:13, 30 June 2017 (UTC)[reply]

Nomination of North-West Europe campaign of 1944–45 for deletion[edit]

A discussion is taking place as to whether the article North-West Europe campaign of 1944–45 is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Wikipedia:Articles for deletion/North-West Europe campaign of 1944–45 until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article. Dicklyon (talk) 05:04, 27 June 2019 (UTC)[reply]